Natrecor (nesiritide), a new IV drug for treating patients who are hospitalized with acute CHF.

September 2001

You'll soon see patients on Natrecor (nesiritide), a new IV drug for treating patients who are hospitalized with acute CHF.

It's in a new drug class...human B-type natriuretic peptide (hBNP).

Natrecor is a recombinant version of this peptide...and has vasodilatory and diuretic effects.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote